In the SIBAMATE study, more than 60% of patients lost at least 5% of body weight after 3 months of using sibutramine-topiramate.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/obesity-treatment-study-backs-dual-drug-strategy-2025a1000pu3?src=rss
Author :
Publish date : 2025-09-26 13:35:00
Copyright for syndicated content belongs to the linked Source.
